The prognostic value of posttransplant chimerism
https://doi.org/10.17650/1818-8346-2008-0-4-31-35
Abstract
Overall survival and relapse rates in 62 patients after allogeneic hemopoietic stem cells transplantation according to posttransplantation chimerism values are presented. Significant differences in 5-year overall survival rate have been found in patients with complete donor and mixed chimerism on days 30 and 100 after transplantation with myeloablative conditioning regimens. The influence of chimerism in different time point after transplantation for relapse rate is shown.
About the Authors
A. A. Sipol
Raisa Gorbacheva Memorial Institute of Children Hematology and Transplantology; Saint-Petersburg Pavlov State Medical University
Russian Federation
Russian Federation
Saint-Petersburg
E. V. Semenova
Raisa Gorbacheva Memorial Institute of Children Hematology and Transplantology; Saint-Petersburg Pavlov State Medical University
Russian Federation
Russian Federation
Saint-Petersburg
I. M. Barkchato
Raisa Gorbacheva Memorial Institute of Children Hematology and Transplantology; Saint-Petersburg Pavlov State Medical University
Russian Federation
Russian Federation
Saint-Petersburg
M. S. Vedjukova
Raisa Gorbacheva Memorial Institute of Children Hematology and Transplantology; Saint-Petersburg Pavlov State Medical University
Russian Federation
Russian Federation
Saint-Petersburg
I. S. Solomonova
Raisa Gorbacheva Memorial Institute of Children Hematology and Transplantology; Saint-Petersburg Pavlov State Medical University
Russian Federation
Russian Federation
Saint-Petersburg
M. V. Prjanishnikova
Raisa Gorbacheva Memorial Institute of Children Hematology and Transplantology; Saint-Petersburg Pavlov State Medical University
Russian Federation
Russian Federation
Saint-Petersburg
A. B. Chukchlovin
Raisa Gorbacheva Memorial Institute of Children Hematology and Transplantology; Saint-Petersburg Pavlov State Medical University
Russian Federation
Russian Federation
Saint-Petersburg
L. S. Zoubarovskaja
Raisa Gorbacheva Memorial Institute of Children Hematology and Transplantology; Saint-Petersburg Pavlov State Medical University
Russian Federation
Russian Federation
Saint-Petersburg
B. V. Afanasyev
Raisa Gorbacheva Memorial Institute of Children Hematology and Transplantology; Saint-Petersburg Pavlov State Medical University
Russian Federation
Russian Federation
Saint-Petersburg
References
1. Афанасьев Б.В., Зубаровская Л.С. Роль трансплантации гемопоэтических стволовых клеток в терапии взрослых больных острыми лейкозами. Онкогематология 2006;1(2):70—85.
2. Афанасьев Б.В., Зубаровская Л.С., Семенова Е.В. и др. Опыт применения трансплантации стволовых гемопоэтических клеток в клинике трансплантации костного мозга СПбГМУ им. акад. И.П. Павлова. Тер арх 2007;79(7):36—43.
3. Румянцев А.Г., Масчан А.А. Трансплантация гемопоэтических стволовых клеток у детей. М.: МИА, 2003.
4. Савченко В.Г., Любимова Л.С., Паровичникова Е.Н. и др. Трансплантация аллогенных и аутологичных гемопоэтических стволовых клеток при острых лейкозах (итоги 20-летнего опыта). Тер арх 2007;79(7):30—5.
5. Büchner T., Hiddemann W., Wörmann B. et al. Acute myeloid leukemia in adults: is postconsolidation maintenance therapy necessary? Int J Hematol 2000;72(3):285—9.
6. McCann S.R., Crampe M., Molloy K. et al. Hemopoietic chimerism following stem cell transplantation. Transfus Apher Sci 2005;32(1):55—61.
7. Ramires M., Diaz M.A., Garcia-Sanchez F. et al. Chimerism after allogeneic hematopoietic cell transplantation in childhood acute lymphoblastic leukemia. Bone Marrow Transplant 1996;18(6):1161—5.
8. Rubnitz J.E., Hijiya N., Zhou Y. et al. Lack of benefit of early detection of relapse after completion of therapy for acute lymphoblastic leukemia. Pediatr Blood Cancer 2005;44(2):138—41.
9. Bader P., Beck J., Frey A. et al. Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT. Bone Marrow Transplant 1998;21(5):487—95.
10. Schmid C., Labopin M., Nagler A. et al. EBMT Acute Leukemia Working Party. Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working Party. J Clin Oncol 2007;25(31):4938—45.
11. Simula M.P., Marktel S., Fozza C. et al. Response to donor lymphocyte infusions for chronic myeloid leukemia is dosedependent: the importance of escalating the cell dose to maximize therapeutic efficacy. Leukemia 2007;21(5):943—8.
12. Socie G., Lawler M., Gluckman E. et al. Studies on hemopoietic chimerism following allogeneic bone marrow transplantation in the molecular biology era. Leuk Res 1995;19(8):497—504.
13. Чухловин А.Б., Фезе Б., Зарайский М.И. и др. Принципы молекулярно-генетической оценки гемопоэтического химеризма и области его применения в гематологии. Вопр гематол онкол иммунопатол педиатр 2003;1(1):70—4.
14. Зарайский М.И., Сипол А.А., Бутлицкий Д.А. и др. Исследование посттрансплантационного химеризма на основе панели биаллельных генных вариантов. Вопр гематол онкол иммунопатол педиатр 2006;5(2):31—4.
15. Alizadeh M., Bernard M., Danic B. et al. Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction. Blood 2002;99(12):4618—25.
16. Бююль А., Цефель П. SPSS: искусство обработки информации. Анализ статистических данных и восстановление скрытых закономерностей. Пер. с нем. СПб.: ООО ДиаСофтЮП, 2001.
Review
For citations:
Sipol A.A., Semenova E.V., Barkchato I.M., Vedjukova M.S., Solomonova I.S., Prjanishnikova M.V., Chukchlovin A.B., Zoubarovskaja L.S., Afanasyev B.V. The prognostic value of posttransplant chimerism. Oncohematology. 2008;(4):31-35. (In Russ.) https://doi.org/10.17650/1818-8346-2008-0-4-31-35
Views:
226
Email this article 